Compton Financial Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$511K Buy
556
+39
+8% +$39.5K 0.11% 39
2025
Q4
$556K Hold
517
0.13% 25
2025
Q3
$394K Hold
517
0.1% 34
2025
Q2
$403K Hold
517
0.1% 32
2025
Q1
$427K Hold
517
0.12% 35
2024
Q4
$399K Sell
517
-22
-4% -$18.2K 0.12% 21
2024
Q3
$478K Sell
539
-55
-9% -$49.4K 0.14% 16
2024
Q2
$538K Hold
594
0.17% 16
2024
Q1
$462K Hold
594
0.16% 16
2023
Q4
$346K Hold
594
0.12% 21
2023
Q3
$319K Hold
594
0.12% 19
2023
Q2
$279K Hold
594
0.11% 25
2023
Q1
$204K Hold
594
0.08% 32
2022
Q4
$217K Buy
+594
New +$211K 0.09% 31

Other funds holding LLY

Compton Financial Group's LLY Position: Q1 2026 in Review

Compton Financial Group increased its Eli Lilly (LLY) stake by 7.5% in Q1 2026, buying an estimated $39.5K and bringing the position to 556 shares worth $511K. The position accounts for 0.11% of the portfolio, ranked #39.

Compton Financial Group first reported a position in LLY in Q4 2022 and has held it in 14 quarters since. The position peaked at $556K in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Compton Financial Group held 556 shares of Eli Lilly worth $511K as of Q1 2026.
  • Compton Financial Group bought 39 Eli Lilly shares in Q1 2026, an estimated $39.5K.
  • Eli Lilly made up 0.11% of Compton Financial Group's portfolio in Q1 2026, its #39 holding.
  • Compton Financial Group first reported a position in Eli Lilly in Q4 2022 and has held it in 14 quarters since.
  • Compton Financial Group's Eli Lilly position peaked at $556K in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Compton Financial Group's 13F filing for Q1 2026, filed 28 Apr 2026.